Search research articles
Contact Us
Filters
Showing results (31-40 of 51) with videos related to
Page
of 6
Sort By:
The Journal of Biological Chemistry
|
November 25, 1981
Studies on the mechanism of denaturation of cytochrome P-450 by cyclophosphamide and its metabolites
H L Gurtoo, A J Marinello, R F Struck, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
August 1, 1981
Metabolism and macromolecular binding of the carcinogen Michler's ketone in rats
R F Struck, T W Shih, T P Johnston, et al.
British Journal of Cancer
|
January 1, 1983
Isophosphoramide mustard, a metabolite of ifosfamide with activity against murine tumours comparable to cyclophosphamide
R F Struck, D J Dykes, T H Corbett, et al.
Biochemical Pharmacology
|
February 1, 1991
Identification of 7-(2-hydroxyethyl)guanine as a product of alkylation of calf thymus DNA with clomesone
R F Struck, J A Alexander, D M McCain, et al.
Cancer Biochemistry Biophysics
|
July 1, 1986
Nature of the binding of activated cyclophosphamide to calf thymus DNA and pBR-322 plasmid DNA
S K Bansal, J H Love, M B Faletto, et al.
Cancer Chemotherapy and Pharmacology
|
August 8, 2001
Acyl derivatives of demethylpenclomedine, an antitumor-active, non-neurotoxic metabolites of penclomedine
R F Struck, A Tiwari, H S Friedman, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
November 1, 1990
Disposition and metabolism of carbovir in mice dosed intravenously or orally
S M el Dareer, K F Tillery, L M Rose, et al.
Cancer Treatment Reports
|
October 1, 1977
Distribution and metabolism of prednisone in mice, dogs, and monkeys
S M El Dareer, R F Struck, V M White, et al.
Cancer Research
|
May 15, 1987
Plasma pharmacokinetics of cyclophosphamide and its cytotoxic metabolites after intravenous versus oral administration in a randomized, crossover trial
R F Struck, D S Alberts, K Horne, et al.
Cancer Research
|
September 1, 1982
Protective role of thiols in cyclophosphamide-induced urotoxicity and depression of hepatic drug metabolism
M J Berrigan, A J Marinello, Z Pavelic, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 51) with videos related to
Sort By:
Page
of 6
The Journal of Biological Chemistry
|
November 25, 1981
Studies on the mechanism of denaturation of cytochrome P-450 by cyclophosphamide and its metabolites
H L Gurtoo, A J Marinello, R F Struck, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
August 1, 1981
Metabolism and macromolecular binding of the carcinogen Michler's ketone in rats
R F Struck, T W Shih, T P Johnston, et al.
British Journal of Cancer
|
January 1, 1983
Isophosphoramide mustard, a metabolite of ifosfamide with activity against murine tumours comparable to cyclophosphamide
R F Struck, D J Dykes, T H Corbett, et al.
Biochemical Pharmacology
|
February 1, 1991
Identification of 7-(2-hydroxyethyl)guanine as a product of alkylation of calf thymus DNA with clomesone
R F Struck, J A Alexander, D M McCain, et al.
Cancer Biochemistry Biophysics
|
July 1, 1986
Nature of the binding of activated cyclophosphamide to calf thymus DNA and pBR-322 plasmid DNA
S K Bansal, J H Love, M B Faletto, et al.
Cancer Chemotherapy and Pharmacology
|
August 8, 2001
Acyl derivatives of demethylpenclomedine, an antitumor-active, non-neurotoxic metabolites of penclomedine
R F Struck, A Tiwari, H S Friedman, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
November 1, 1990
Disposition and metabolism of carbovir in mice dosed intravenously or orally
S M el Dareer, K F Tillery, L M Rose, et al.
Cancer Treatment Reports
|
October 1, 1977
Distribution and metabolism of prednisone in mice, dogs, and monkeys
S M El Dareer, R F Struck, V M White, et al.
Cancer Research
|
May 15, 1987
Plasma pharmacokinetics of cyclophosphamide and its cytotoxic metabolites after intravenous versus oral administration in a randomized, crossover trial
R F Struck, D S Alberts, K Horne, et al.
Cancer Research
|
September 1, 1982
Protective role of thiols in cyclophosphamide-induced urotoxicity and depression of hepatic drug metabolism
M J Berrigan, A J Marinello, Z Pavelic, et al.
Page
of 6